Contact us
Privacy Policy
Terms & Conditions
Email Whitelisting
Staying Healthy
GLP-1s fail to slow progression of Alzheimer’s: Novo Nordisk
0
Share:
The trials showed an effect on Alzheimer’s biomarkers, though Novo did not specify which ones.
Share:
More Stories
Staying Healthy
Kroger to pay nearly $1.4 billion to settle opioid lawsuit claims
Staying Healthy
Ocasio-Cortez: RFK Jr. would take US back to ‘1700s, 1800s’
Generated by
Feedzy
